Ark Invest bought $16.2M of Nvidia and $16.0M of CoreWeave last week, while selling $12.8M of Tempus AI and $9.1M of Block.
Detailed price information for Fluence Energy Inc Cl A (FLNC-Q) from The Globe and Mail including charting and trades.
Tempus is rated hold as valuation reflects future success.
Tempus AI Q3 results show 23% revenue growth, soaring diagnostics, and key pharma partnerships. Read here for more on TEM stock.
Tempus AI has delivered a strong year to date gain, and a stream of new partnerships and regulatory milestones has helped keep the stock in focus. With the share price moving faster than many investors can track the underlying business, the key issue now is whether Tempus AI's current market value is still grounded in its sales. Year to date, the stock is up 25.8%, which puts real pressure on the question of whether recent top line performance can support that kind of re-rating based on...
These are some of the stocks posting the largest moves midday.
Moby summary of Tempus AI, Inc.'s Q3 2026 earnings call
Tempus AI raised its outlook on 23% revenue growth, but most of its smaller net loss came from paper gains on stock it holds, not the core business.
Tempus AI (NASDAQ:TEM) shares climbed almost 10% on Monday after the healthcare technology company reported third-quarter revenue and adjusted earnings ahead of Wall Street expectations, while raising its full-year guidance. The company generated revenue of US$411.5 million in the third...
Tempus AI reported better-than-expected third-quarter earnings.
Implied volatility currently sits at 87%, close to the highest levels for Tempus AI stock in the last 12 months.
Tempus AI sits at the intersection of AI infra and clinical diagnostics. It's a holding in both the ROBO Global Artificial Intelligence ETF and the ROBO Global Healthcare and Innovation ETF.
Bristol Myers Squibb and Tempus AI partner with Pathos AI to advance Alzheimer’s research with AI-driven datasets and smarter trials. Read more here.
This is the newest page. Registered accounts read further back.